ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2022 Congress

July 9-13, 2022. London, England, UK.

View by Title View by Number View Themes
Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB0019

    Bambi-deficiency enhances adipose tissue browning, ameliorates dyslipidemia and confers protection against atherosclerosis

    C. Lee1, O. Merhi El Hassan El Abdallah1, J. Monkman1, K. Woollard1, J. Crawley1, I. Salles-Crawley2

  • Abstract Number: OC 01.1

    Base and Prime editing of DNA as a new therapeutic option for Hemophilia A

    E. Tonetto1, S. Pignani2, G. Roman2, A. Follenzi2, F. Bernardi3, D. Liu4, M. Pinotti1, D. Balestra1

  • Abstract Number: PB0257

    Benefits of prolonged anticoagulant treatment in a series of cerebral venous thrombosis in pediatric patients

    R. Berrueco1, A. Faura2, A. Ruiz-Llobet3, M. Mesegué4, M. Solsona3, E. González-Forster3

  • Abstract Number: PB0699

    Bevacizumab for refractory hereditary hemorrhagic telangiectasia

    C. Almeida1, A. Sarmento1, S. Carvalho2, G. Ferreira2

  • Abstract Number: PB0542

    Bio-equivalence of Potency adjusted approved heparin solutions compared to a newly developed heparin solution.

    E. Krupa1, D. Hoppensteadt2, W. Jeske1, A. Farooqui1, A. Kouta1, O. Iqbal1, B. Kantarcioglu3, R. Krämer4, J. Fareed2

  • Abstract Number: VPB1284

    Biomarker Profiling to Investigate the Molecular and Cellular Pathogenesis of Endothelium in Atrial Fibrillation

    G. Dungan1, A. Odeh1, F. Siddiqui1, D. Hoppensteadt2, O. Iqbal1, A. Darki2, J. Fareed2, m. syed1

  • Abstract Number: PB0082

    Biomarkers in COVID-19: Association with disease severity and outcomes

    M. Peralta1, V. Muczynski2, P. Lane3, L. Pagala3, A. Riddell3, S. Bhagani4, B. Agarwal5, K. Gomez6, A. Drebes3, J. McVey7, T. Kotecha8, D. Martin8, A. Davenport8, A. Laurence9, A. Brachat10, T. Sood8, L. Lanning3, T. Gandhi3, P. Chowdary11

  • Abstract Number: VPB0940

    Biomarkers of coagulopathy in patients with different types of acute leukemia

    Y. Hisada1, S. Archibald1, K. Bansal2, S. Dwarampudi2, A. Mullen2, S. Bhatia2, R. Bhatia2, N. Mackman1, R. Gangaraju2

  • Abstract Number: PB1291

    Biomarkers of endothelial cell dysfunction in HIV-infected patients

    E. Mayne1, T. Abdool-Carim2, M. Lederman3, N. Funderburg4, S. Louw5

  • Abstract Number: PB0306

    Biomarkers of HIV-associated thrombotic thrombocytopaenic purpura (HIV-TTP)

    S. Louw1, M. Gededzha2, A. Mayne3, E. Mayne4

  • Abstract Number: OC 05.4

    Biphasic thrombus formation and resolution during a coronavirus infection in the liver

    M. Salzmann1, J. Kral-Pointner1, P. Gibler1, J. Wojta1, R. Plasenzotti1, P. Hohensinner2

  • Abstract Number: PB0728

    Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro

    R. Herranz1, J. Oto1, M. Hueso2, E. Plana3, F. Cana2, A. Fernández-Pardo2, S. Bonanad4, C. Vera-Donoso5, M. Martínez-Sarmiento5, P. Medina2

  • Abstract Number: PB0670

    Bleed Outcomes in the Moderate and Mild Hemophilia A Population Without Prophylactic Treatment in CHESS II and CHESS PAEDs

    K. Khair1, F. Nissen2, E. Ferri-Grazzi3, J. O’Hara4, R. Ofori-Asenso5, M. Aizenas2, H. Zhang2, K. Moreno2, T. Burke4, B. Nolan6

  • Abstract Number: PB0181

    Bleeding according to FVIII activity in 641 children with non-severe haemophilia – data from the PedNet study group

    M. de Kovel1, C. Königs2, S. Ranta3, C. Escuriola Ettingshausen4, K. Fischer5

  • Abstract Number: PB0237

    Bleeding assesment in children with Noonan syndrome

    A. Barg1, E. Avishai2, S. levy1, y. yeshayahu1, T. Livnat2, G. Kenet3

  • Abstract Number: PB1237

    Bleeding diathesis in a girl with biallelic variants in RASGRP2 gene affecting platelet CalDAG-GEFI function

    J. Frontroth1, M. Hepner2, K. Downes3, C. Cervio1, S. Annetta4, R. Sueldo5, B. Bianco6, G. Sciuccati7

  • Abstract Number: PO0002

    Bleeding disorder in a critically ill patient

    R. Pombal1, L. Vieira2, S. Lopes2, R. Neto2, J. Ribeiro2, H. Gomes2, M. Figueiredo3

  • Abstract Number: OC 70.5

    Bleeding in non-severe haemophilia A and B – data from the PedNet study group.

    M. de Kovel1, C. Königs2, S. Ranta3, C. Escuriola Ettingshausen4, K. Fischer5

  • Abstract Number: OC 34.1

    Bleeding in Patients with Genitourinary Cancer compared to Non-Genitourinary Cancer Treated with Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism

    T. Lang1, D. Vlazny1, D. Houghton1, A. Casanegra1, R. Meverden1, D. Froehling1, D. Hodge2, L. Peterson1, R. McBane1, W. Wysokinski1

  • Abstract Number: VPB1191

    Bleeding of unknown cause or Unclassified Bleeding Disorder : single center experience in west Algeria.

    B. DRISS1, M. Moueden2

  • Abstract Number: OC 71.3

    Bleeding Outcomes for Patients on Anticoagulant and Antiplatelet Therapy

    J. Schaefer1, J. Errickson1, X. Kong1, M. Ali2, S. Edupuganti1, B. Haymart1, S. Kaatz3, D. DeCamillo1, E. Kline-Rogers4, V. Shah3, S. Sood1, J. Froehlich4, G. Barnes1

  • Abstract Number: PB0192

    Bleeding Rates in Severe Non-inhibitor Haemophilia A Patients Across US, EU4&UK and Japan

    A. Amirah1, I. Palau2, A. Rosli1, N. Allie2

  • Abstract Number: PB0499

    Bleeding risk assessment in end-stage kidney disease: validation of existing risk scores and evaluation of a machine learning-based approach

    S. Nopp1, C. Spielvogel1, S. Schmaldienst2, R. Klauser-Braun3, M. Lorenz4, B. Bauer5, I. Pabinger5, M. Säemann6, O. Königsbrügge7, C. Ay5

  • Abstract Number: PB0056

    Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation

    N. Gendron1, L. Khider2, C. Le Beller2, B. Espinasse3, C. Auditeau2, W. Amara2, G. Perrin2, D. Lebeaux2, A. Gaiffe4, S. Combret5, B. Bertin6, T. Mirault2, D. Smadja7, O. Sanchez8, C. Tromeur9, B. Planquette10, F. Couturaud11

  • Abstract Number: PB0709

    Bleeding Story of An Adolescent: Factor VII Deficiency And Repeat Iliopsoas Bleeding

    S. KARAMAN1, A. UNUVAR2, ş. şahin3, C. Ercan4, g. polat4, M. BILICI1, D. TUGCU1, G. TANYILDIZ1, Z. KARAKAS1

  • Abstract Number: PB0331

    Bleeding tendency in thrombocytopenic patients due to impaired defects in primary and secondary hemostasis

    N. Buntsma1, A. Gasecka2, S. Talsma3, J. Rytel4, K. Mądry4, G. Basak4, E. van der Pol5, R. Nieuwland6

  • Abstract Number: PB0908

    Bleeding versus thrombosis: Case series on dilemma of VTE management in cancer patients and role of radiotherapy

    A. Bolarinwa, O. Popoola, M. Elebute

  • Abstract Number: PB1050

    Blockade of K-ras signalling prevents coagulatory phenotype of alternatively activated macrophages.

    P. Haider1, J. Kral-Pointner2, M. Salzmann2, B. Podesser3, J. Wojta2, P. Hohensinner3

  • Abstract Number: PB0210

    Blood Biodistribution and Vector Shedding of Valoctocogene Roxaparvovec in People with Severe Hemophilia A: Results from the Phase 3 GENEr8-1 Trial

    S. Agarwal1, K. Obrochta1, M. Vora1, A. Bowen1, B. Bunch1, J. Holcomb1, D. Guo1, T. Robinson2, K. Jayaram1, C. Russell1, C. Vettermann1, J. Henshaw1

  • Abstract Number: VPB0134

    Blood coagulation parameters in hospitalized patients with COVID-19 – data from Regional Center for transfusion medicine Shtip

    M. SHOROVA1, r. Grubovik-Rastvorcev2, E. Petkovic3, D. Stambolieva4, N. Jovanova5

  • Abstract Number: PB0351

    Blood transfusion maintains endothelial cell quiescence – implications in the prevention of stroke in paediatric sickle cell anaemia

    H. Fogarty1, S. Ward2, E. Karampini2, S. Elliott3, A. Rehill2, A. Ahmad2, J. Velasquez2, R. Geoghegan4, H. Conroy4, M. Byrne5, U. Budde6, E. Tuohy7, C. McMahon4, J. O'Donnell2

  • Abstract Number: VPB0114

    BNT162b2 mRNA SARS-CoV-2 vaccination does not cause upregulation of endothelial activation markers or hypercoagulability: A Prospective, Single-Arm, Longitudinal Study.

    X. Lim1, B. Leung2, C. SUM3, G. Lim4, C. CHUA1, T. TU5, K. RAMANATHAN6, M. HUANG2, H. HOWE1, B. Fan7

  • Abstract Number: OC 29.1

    Both α- and γ-chain crosslinks mediated by FXIIIa affect fibrin fibre resistance to rupture

    T. Feller1, C. Duval2, S. Connell3, R. Ariëns4

  • Abstract Number: OC 03.3

    Bradykinin Liberation from High Molecular Weight Kininogen by Plasma Kallikrein on Endothelial Cell Membranes is Modulated by Ambient Concentration of C1 inhibitor and Prolylcarboxypeptidase

    A. Merkulova1, S. Abdalian2, G. Forbes3, P. Zeng3, A. Pinheiro3, A. Schmaier4

  • Abstract Number: OC 48.5

    Brain cancers and the risk of intracranial hemorrhage with Direct Oral Anticoagulants (DOACs) versus Low Molecular Weight Heparin (LMWH): A meta-analysis of comparative studies

    P. Haddad, D. Hammoud, K. Gallagher

  • Abstract Number: PB0199

    Budget impact of increasing rVIII-SingleChain use in patients in Italy with moderate and severe hemophilia A

    S. Yan1, R. Tomic2, M. Panebianco2, E. Dlotko3, L. Stern3, R. Marino4

  • Abstract Number: PB1110

    Buffy-coat-derived megakaryocytes for monoclonal antibody immobilization of platelet antigens (MAIMA) assay

    G. Uzun1, J. Lucic2, K. Althaus3, F. Rigoni4, F. Lyshy1, S. Nowak-Harnau1, I. Marini4, U. Sachs5, T. Backchoul6

  • Abstract Number: PB0825

    Burden of Illness in Patients With von Willebrand Disease Receiving Prophylaxis Versus Potential Prophylaxis-Eligible Patients: A Post-Hoc Analysis of A European Socioeconomic Study

    P. Du1, G. Morgan2, S. Brighton2, F. Truong Berthoz3, N. Kemenyash3, S. Sun1

  • Abstract Number: PB0654

    Burden of Treatment for Adult and Adolescent People with Haemophilia (PwH): Concept Elicitation Results Supporting the Development of the Hemophilia Treatment Experience Measure (Hemo-TEM)

    M. Brod1, L. Waldman2, J. Skov Neergaard3, A. Busk3

Jump to:  View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley